End-stage kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Dialysis participants in our hospital; 2. 3 months after the first dialysis treatment; 3. Have specific contact information and contacts, and can be followed up regularly; 4. Freely given informed consent.
Exclusion criteria
Exclusion criteria: 1. Participants who have occured major adverse cardiovascular events (non-fatal myocardial infarction, target lesion revascularization (PCI/CABG), and non-fatal stroke) during last 3 months; 2. Complicated with advanced malignant tumor or AIDS or severe infection or shock; 3. Women during pregnancy; 4. Participants who have had heart valve surgery; 5. Participants who have serious mental or psychological disorders, which affect compliance seriously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Atrial fibrillation;Unstable angina pectoris;Acute heart failure;Vascular access technical failure;Rehospitalization due to cardio-cerebrovascular disease;Peritonitis;Catheter-related infection;Incidence of falling;Fracture;Malignant tumor;All-cause mortality; | — |
Countries
China
Contacts
Peking University Shenzhen Hospital